» Articles » PMID: 25695887

Comparative Efficacy of Radiofrequency and Laser Ablation for the Treatment of Benign Thyroid Nodules: Systematic Review Including Traditional Pooling and Bayesian Network Meta-analysis

Overview
Specialty Endocrinology
Date 2015 Feb 20
PMID 25695887
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare the efficacy of radiofrequency ablation (RFA) and laser ablation (LA) for treatment of benign solid thyroid nodules, using a systematic review including traditional pooling and Bayesian network meta-analysis.

Materials And Methods: A comprehensive literature search in PubMed-MEDLINE, EMBASE, and the Cochrane Library databases identified prospective studies evaluating the percentage mean change [absolute mean change (mL)] in nodule volume after RFA or LA. Studies from January 1, 2000, to November 1, 2013, were included. Review of 128 potential papers, including a full-text review of 33, identified 10 eligible papers covering a total of 184 patients for meta-analysis. The percentage mean change [absolute mean change] in nodule volume over a 6-month follow-up was compared between RFA and LA.

Results: Based on the traditional frequentist approach, the pooled percentage mean changes (95% confidence interval) of RFA and LA were 76.1% (70.1-82.1) and 49.9% (41.4-58.5), respectively, and the pooled absolute mean changes (95% confidence interval) of RFA and LA were 8.9 mL (6.6-11.2) and 5.2 mL (4.3-6.1), respectively. Based on the Bayesian network meta-analysis, RFA achieved a larger pooled percentage mean change (95% credible interval) and absolute mean change (95% credible interval) compared to LA [77.8% (67.7-88.0) vs 49.5% (26.7-72.4), and 9.2 mL (5.8-11.9) vs 5.3 mL (2.1-8.5), respectively]. The RFA group has the highest probability of having the most efficacious treatment (98.7%). There were no major complications after either RFA or LA.

Conclusions: RFA appears to be superior to LA in reducing benign solid thyroid nodule volume, despite the smaller number of treatment sessions without major side effects.

Citing Articles

Efficacy and safety of radiofrequency ablation for secondary hyperparathyroidism: a systematic review and meta-analysis.

Li M, Jiang H, Wang Y, Li F Asian Biomed (Res Rev News). 2024; 18(6):287-296.

PMID: 39697216 PMC: 11650422. DOI: 10.2478/abm-2024-0036.


Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management.

Chan W, Chiang P, Lin A, Chang Y, Lin W Ultrasonography. 2024; 43(6):395-406.

PMID: 39397446 PMC: 11532522. DOI: 10.14366/usg.24083.


Comparative Analysis of AI-SONICTM Thyroid System and Six Thyroid Risk Stratification Guidelines in Papillary Thyroid Cancer: A Retrospective Cohort Study.

Wang M, Yang S, Yang L, Lin N Ther Clin Risk Manag. 2024; 20:515-528.

PMID: 39193477 PMC: 11348989. DOI: 10.2147/TCRM.S458576.


Assessing the relative effectiveness of various ultrasound-guided ablation techniques for treating benign thyroid nodules: A systematic review and network meta-analysis.

Sun X, Chen J, Zou Y, Lei J, Liu W Medicine (Baltimore). 2024; 103(18):e38014.

PMID: 38701262 PMC: 11062690. DOI: 10.1097/MD.0000000000038014.


Radiofrequency ablation of thyroid nodules: a clinical review of treatment complications.

Issa P, Cironi K, Rezvani L, Kandil E Gland Surg. 2024; 13(1):77-86.

PMID: 38323235 PMC: 10839694. DOI: 10.21037/gs-22-539.